AGP Executive Report
Last update: 8 hours agoAI Infrastructure Push: China plans a 2 trillion yuan ($295B) nationwide AI data-center network over five years, relying on domestic chips and state-backed operators to reduce dependence on US suppliers. Brain-Tech Breakthrough: China approved the world’s first commercial brain-computer chip (NEO) for spinal cord injury and paralysis, as Neuralink still awaits FDA clearance. Biotech & Regulation: China’s NMPA approved Akeso’s gumokimab for moderate-to-severe plaque psoriasis, with an additional ankylosing spondylitis review accepted. Digital Cancer Care: A Hong Kong trial found the SUPPORT+ smartphone app plus nurse follow-up helped advanced cancer patients maintain quality of life and reduce unplanned hospitalizations. Heart Health Gap: Global Heart Hub reports women often delay seeking care and face recognition gaps for cardiovascular disease. Public Health & Safety: Hong Kong’s CHP is investigating severe pediatric COVID-19 cases and urges vaccination for high-risk children. Water Access in Practice: China-aid borehole projects in Zimbabwe reached 300 villages, improving access to clean water and cutting waterborne disease risk. China-US Tensions in Health Tech: WuXi AppTec sued the US Defense Department over its blacklist designation, arguing the move is unsupported.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.